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AB S T R A CT  
When a patient experiences trauma, pre-hospital rapid sequence 
intubation (RSI) is often the course of action. While RSI is 
associated with favorable neurological outcomes among traumatic 
brain injury patients, it also carries the risk of increased hypotension 
and bradycardia. Ketamine is a fast-acting anesthetic agent used in 
RSI, attractive due to its ability to raise heart rate (HR) and blood 
pressure (BP) and thus potentially lessening the severity of RSI-
related hypotension and bradycardia. However, research in support 
of its use is inconclusive, with different studies reporting increases 
or decreases in BP and HR after ketamine administration. To study 
the effect of ketamine on HR and BP during RSI, we analyzed the 
data obtained from 1,516 patients who received trauma and non-
trauma medical care including RSI from first responders and 
emergency personnel using two different statistical methods. We 
determined if there was any association between the vital signs prior 
to administration of ketamine and outcomes such as bradycardia 
and/or hypotension post-ketamine administration in patients 
undergoing RSI. We found that the vital signs prior to 
administration of ketamine (i.e. BP and HR) predict the 
development of bradycardia and/or hypotension in patients 
undergoing RSI and the relationship between baseline vital signs 
and the development of bradycardia and/or hypotension is 
moderated by the dose of ketamine. Results obtained from this 
study may help responders and emergency care personnel to 
identify the patients that are likely to benefit from ketamine as an 
anesthetic agent. 
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1 Introduction 
Acute trauma patients often require pre-hospital advanced trauma life support, including intubation, during 
which a plastic tube is inserted into the trachea to keep the airway open or to serve as a channel for 
administering certain drugs. In most emergency cases, the best technique of choice is rapid sequence 
intubation (RSI). RSI involves administration of a fast-acting sedative (i.e. induction), along with a rapid 
neuromuscular blocker to facilitate endotracheal tube insertion [1]. Pre-hospital RSI is associated with a 
favorable neurological outcome over in-hospital intubation among traumatic brain injury patients [2]. RSI 
is a life-saving emergent procedure, yet it is not devoid of complications [3]. The complications that 
commonly occur with intubation and may be associated with a number of negative outcomes include: 
increased morbidity and mortality [4], oxygen desaturation [1], failed intubation, hypoxia, hypotension, and 
bradycardia [5]. A significant safety concern regarding sedative use in emergent conditions is the risk of 
hypotension and cardiovascular collapse especially in the critically ill such as trauma patients or those with 
pre-existing comorbid conditions. Furthermore, RSI may exacerbate hypotension in trauma patients taking 
benzodiazepines [6]. Despite these negative effects, the use of anesthesia remains necessary during 
intubation as it improves intubating conditions and minimizes procedure-associated adverse 
neuroendocrine responses that lead to hypertension and tachycardia and elevated intracranial pressure [7]. 
In order to optimize the performance of RSI and reduce complications, one must select the best sedative 
agent and dose most appropriate for the clinical scenario. Some of the commercially available sedatives that 
are used during intubation are etomidate, benzodiazepines, propofol, and barbiturates. Among the 
complications of RSI, hypotension (low BP) and bradycardia (low HR) are the key concerns for trauma 
surgeons. In head trauma patients, mortality rises from 1% in patients with hypoxia alone to 7% in patients 
with hypoxia and hypotension. Furthermore, more than one-half of head trauma patients experience 
bradycardia associated with RSI [8] . These statistics underscore the need to devise strategies to prevent or 
minimize these conditions among trauma patients who require intubation. This study aims to shed light on 
the cardiovascular effects of ketamine, a commonly used anesthetic in trauma patients, with particular focus 
on these two important outcomes.  
Recently, ketamine has been gaining interest as a sedative agent in RSI. Ketamine effectively induces 
anesthesia, sedation, and amnesia without compromising airway protection or spontaneous respiratory 
efforts. It also exhibits a favorable hemodynamic profile making it an ideal agent for RSI in trauma patients 
[9]. Current literature reporting on the use of ketamine to facilitate ETI in the EMS setting remains scarce. 
Moreover, only a handful reported changes in hemodynamic measures due to ketamine, and those were 
inconclusive, with some studies reporting increases and others decreases in BP and HR. It is also unclear if 
varying baseline hemodynamic measurements alters the ketamine response. Ketamine was discovered in 
1962 and following FDA approval was given to American soldiers during the Vietnam war. Ever since, it 
has been used as a widespread anesthetic and has been placed in the ‘core’ list in the WHO’s essential drugs 
list [10]. Ketamine is a dissociative anesthetic that is administered intravenously and is available in multiple 
strengths, including 10 mg/ml, 50 mg/ml, and 100 mg/ml. Ketamine works within 5 minutes, and a dose 
ranging from   1 - 4 mg/kg is enough to induce a dissociative state [11] . Unlike other sedatives that depress 
the reticular activating system, ketamine affects the limbic system preventing sensory stimuli from traveling 
to the cerebral cortex. As a result, ketamine produces an anesthetic effect without impairing breathing. It 
also stimulates the brain stem leading to catecholamine release and inhibition of norepinephrine reuptake, 
ultimately causing an increase in heart rate (HR) and blood pressure (BP) [12]. Thus, if a patient 
demonstrates bradycardia and hypotension as a result of intubation, ketamine may potentially raise the HR 
and BP closer to normal levels [13] . Ketamine is also unique in that it provides analgesic effects along with 
its amnestic and sedative effects. These distinctive properties have made ketamine a compelling option for 
anesthesia induction in both pre-hospital and in-hospital settings. In this study, we examined the effect of 
ketamine on HR and BP and identified potential predictors of the occurrence of three important post-
ketamine clinical outcomes: bradycardia, hypotension and hypertension. 
22 
 
 ISSN: 2456-7108 
Available online at Journals.aijr.in 
Sheth et al., Adv. J.  Grad.  Res.; Vol. 3 Issue 1, pp: 20-33, January 2018 
1.1 Effects of Ketamine on Vital Signs in the In-hospital Setting 
A number of studies have investigated the impact of ketamine on vital signs (VS) during in-hospital care. 
Ayatollahi et al. [14] compared ketamine, lidocaine, and ephedrine to placebo with regards to their effects 
on BP and HR in 140 surgical patients undergoing anesthesia using propofol. The researchers found that, 
compared to placebo, ketamine was associated with slightly lower systolic BP (SBP) but had no impact on 
HR [14] . Rajan et al. [15] randomized 40 patients undergoing caesarean section to receive either ketamine 
or normal saline (NS) prior to induction of anesthesia and intubation. VS of both groups were compared 
and it was found that ketamine was associated with significantly lower SBP and HR than placebo. HR and 
SBP were comparable between the ketamine and saline groups prior to intubation, but after intubation 
these variables were higher in the control group. Furthermore, HR and SBP were lower than the baseline 
readings in the ketamine group [15] . This study supports the BP lowering effect of ketamine reported by 
Ayatollahi et al. [14]. Other studies have reported conflicting results to Ayatollahi et al. [14] and Rajan et al. 
[15] with respect to ketamine’s effect on BP and HR.  Ozkan et al. [16] compared the effects of ketamine 
to placebo in 60 patients undergoing transurethral resection for benign prostatic hyperplasia. Patients who 
received ketamine demonstrated significantly higher mean arterial pressure (MAP), SBP, and HR than the 
placebo group [16]. Generally, patients receiving spinal anesthesia experience a drop in VS. In this study, 
the ketamine group experienced a less severe drop than the placebo group [16] . Similar findings were 
reported in a study of 54 children undergoing adenotonsillectomy who received either ketamine or alfentanil 
in adjunct to propofol and rocuronium for induction of anesthesia [17]. The researchers found that the 
ketamine group demonstrated an overall increase in BP and HR. The MAP initially dropped after intubation 
in the ketamine group but it rebounded within one minute to levels above baseline. Barois et al. [18] studied 
the effects of ketamine use prior to endotracheal intubation (ETI) in newborns. Ketamine was administered 
to 37 out of 59 preterm infants undergoing intubation. Newborns given ketamine were found to have 
significant increases in HR over the controls (150.7 versus 112.6 bpm) although BP was slightly lower in 
the ketamine group (30.0 versus 32.9 mmHg). Therefore, the authors suggested that ketamine given prior 
to intubation is effective in preventing bradycardia in pre-term infants [18] .  
The effect of ketamine on HR and BP in trauma patients is somewhat inconclusive and controversial 
between studies. Previous studies regarding ketamine use during intubation in an in-hospital setting have 
reported variable results with respect to its effect on BP and HR. For example, Ayatollah et al. [14] and 
Rajan et al. [15] reported decreased BP and HR [15], [19] while Ozcan et al. [16] and Kim et al. [17], reported 
an increase in both of these parameters after ketamine administration. Barois et al. [18] reported decreased 
BP but an increase in HR. The differences in results reported by various studies could be due in part to 
differences in study populations (age, sex, co-conditions, etc.), indications of the anesthetic, route of 
administration, use of additional drugs, and perhaps dosing. In the study conducted by Ayatollah et al. [14] 
patients received a combination of three drugs, which could have potentially modified the ketamine 
response. Also, patient characteristics varied widely between the studies, notably in sex and age, for example 
Rajan et al. [15] studied pregnant women, Ozcan et al. [16] studied older men with BPH, Kim et al. [17] 
studied children and Barios et al. [18] studied neonates. Also, the route of administration differed between 
the studies. For example, Ozcan et al. [16] delivered spinal anesthesia while others gave injections.    
1.2 Effects of Ketamine on Vital Signs in the Pre-hospital Setting 
 To date, very few studies have addressed the use of ketamine in the pre-hospital setting. Losvik et al. [20] 
compared the effects of ketamine, pentazocine, and placebo on VS in adult trauma patients prior to 
hospitalization. Compared with pentazocine and placebo, patients who received ketamine demonstrated an 
increase in BP [20] . Likewise, Tran et al. [21] compared the hemodynamic profiles of ketamine and 
morphine given for analgesia in 312 trauma patients prior to hospitalization. On average, patients who 
received ketamine had higher increases in BP from baseline than those who received morphine (9.3 mmHg 
vs. 8 mmHg). The authors concluded that ketamine provides a comparable analgesic effect to morphine, 
yet with a lower risk of airway complications and hypotension [21]. A review of 115 trauma patients who 
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underwent pre-hospital intubation found that laryngoscopy and intubation caused significant increases in 
HR and MAP or SBP and that prior administration of 100 mg of ketamine moderately decreased the SBP, 
and slightly decreased the MAP with a minimal to no effect on HR. However, none of these differences 
were statistically significant when compared to controls [7]. A similar discrepancy on the effects of ketamine 
was seen between studies pertaining to the use of ketamine for trauma patients in the pre-hospital setting. 
Both Lovsik et al. [20] and Tran et al. [21] reported increased BP. while Perkins et al. [7] reported decreased 
BP. The results of Perkins et al. [7] were not statistically significant and might have been underpowered. 
Nonetheless, there is a clear variation in the literature regarding VS changes associated with ketamine 
administration in trauma patients in the pre-hospital setting.  
1.3  Rationale and Hypothesis 
The discrepancies that exist in the literature surrounding the use of ketamine in RSI justify additional 
investigation. Researchers do not yet agree on how ketamine affects BP and HR. However, this information 
is of vital importance to first responders, surgeons, and emergency department personnel. If RSI increases 
mortality and the incidence of negative effects such as hypoxia, hypotension, and bradycardia, then surgeons 
must be able to anticipate which patients are at risk of developing such effects.  
The goal of this study was to examine whether VS taken prior to ketamine administration for RSI can 
predict subsequent occurrence of hypotension and/or bradycardia in both trauma and medical patients in 
the pre-hospital setting. The research literature is unclear as to whether varying baseline hemodynamic 
measurements effect how patients respond to ketamine.  When RSI leads to bradycardia and hypotension 
in a trauma patient and the use of ketamine raises both of these parameters, the use of ketamine becomes 
useful in the field and may benefit this particular subset of patients by bringing up their HR and BP. 
However, while this is the case in some studies, in others, ketamine seemed to have the opposite effect and 
caused both BP and HR to decrease. As a result, it may be difficult for first responders, ER personnel and 
trauma surgeons to determine who will benefit from ketamine’s hypertensive and tachycardic effects versus 
those who will develop hypotension and/or bradycardia. Therefore, we hypothesized that baseline 
hemodynamic measures (VS) may predict how patients respond to ketamine administration in terms of 
changes in their BP and HR. To further clarify the determinants of the ketamine response in patients 
undergoing RSI we also looked at the effects of different doses on the hemodynamic response. This will 
enable healthcare professionals to improve upon current mortality and morbidity rates associated with RSI. 
Furthermore, the results of our study may also potentially aid physicians in identifying patients in whom 
ketamine is likely to induce a favorable effect from those who are likely at risk of developing hemodynamic 
instability and subsequent complications. Our results also outline the importance of categorizing and 
carefully looking at the characteristics of each patient before deciding the way to go in terms of airways 
protection. While follow-up studies are required before this idea goes into practice, our study provides a 
better understanding of the factors that predict unfavorable outcomes following ketamine induction.  
2 Methods 
2.1 Definitions 
For the purpose of this study the following definitions were used: RSI refers to the administration of a 
sedative (in this case ketamine) to induce general anesthesia prior to ETI; Bradycardia is a HR < 60; 
Hypotension is a MAP  70; Normotension is a SBP < 130 and > 90 and a diastolic BP (DBP) < 85 and 
> 60; Hypertension is a MAP of  105; and the Shock Index (SI) is defined as the HR/ SBP (normal SI= 
0.5 - 0.7) and it indicates the level of occult shock. The MAP was derived from the SBP and DBP using the 
following formula: MAP= 1/3(SBP-DBP) + DBP. Baseline HR, SBP and DBP measurements were 
recorded prior to RSI.  
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2.2 Study Design and Data Collection 
Table 1: Descriptive Characteristics of Study Sample 
The study is a retrospective analysis of 
data obtained from PHI Air Medical 
(PHI). PHI is a helicopter emergency 
medical service (HEMS) that safely 
transports more than 30,000 patients 
yearly across the United States. Both 
trauma and medical patients who 
underwent RSI between 2013 and 2016 
and who received ketamine as their 
main induction drug were included in 
the study. Patients were categorized 
into four groups according to their 
received ketamine doses: < 100 
mg/mL, 101-150 mg/mL, 151-200 
mg/mL, and >200 mg/mL. The study 
was non-interventional in the sense that 
each patient received medical care as 
per protocol and patient data was 
collected and entered into medical 
records at the time of HEMS transport 
as per usual practice of PHI. Data 
regarding patient demographics, patient 
category (medical vs. trauma), drug 
doses and hemodynamic measures were 
obtained. Patients with no pulse or an 
un-recordable BP at baseline or after 
ketamine administration were excluded. 
There were no exclusion criteria based on patient demographics, diagnosis and associated medical 
conditions, and concurrent medications or interventions.   
A total of 1,516 patients were included in the study. Of these, 730 were medical patients and 786 were 
trauma patients. The mean age of patients was 50.5 ± 20.3 years (range, 7-94 yrs). The average values for 
pre-ketamine vital signs (SBP, DBP, HR, MAP and SI) as well as the frequencies for post-ketamine 
hemodynamic outcomes (bradycardia, hypotension, and hypertension) are shown in Table 1. The most 
frequently administered ketamine dose was 150-200 mg/mL (n= 629, 41.5%), followed by 101-150 mg/mL 
(n= 489, 32.3%), then  100 mg/ml (n= 266, 17.5%) and lastly > 200 mg/ml (n= 132, 8.7%) (Table 1). 
The Shapiro Wilk test for normality showed post-ketamine pulse (HR) to be normally distributed (p= 0.3) 
while all other vital signs were not normally distributed (p < 0.01). But, given the large sample size (>1000), 
we decided to report parametric tests for bivariate analysis despite our data being non-normal. Additionally, 
we performed the non-parametric equivalent for all comparisons.  
2.3 Outcome Measures 
Three primary outcome variables (i.e., response variables) were tested. These variables reflect changes in 
hemodynamic measurements following administration of ketamine, namely, bradycardia, hypotension, and 
hypertension. Independent (i.e., predictive) variables tested were baseline (pre-ketamine) hemodynamic 
measures (SBP, DBP, HR, MAP and SI), patient age and patient category (medical vs. trauma). Body weight 
was missing in a number of study participants and was therefore excluded from the analysis. 
Characteristics Mean  SD n % 
Socio demographics  
Age  50.5  20.3   
Patient type    
   Medical   730 48.2 
   Trauma   786 51.8 
Pre-ketamine vital signs & dose 
Systolic BP 126.3  33.6   
Diastolic BP  76.2  20.4   
Heart Rate (HR) 100.8  25.7   
Mean arterial pressure (MAP) 92.9  23.9   
Shock index 1.35  .57   
Ketamine dose  
   100 or lower  266 17.5 
   101 to 150  489 32.3 
   151 to 200  629 41.5 
   above 200   132 8.7 
Post-ketamine vital signs 
Systolic BP 122.2 ± 33.5   
Diastolic BP  75.6 ± 21.2   
Heart Rate 101.6 ± 24.6   
Mean arterial pressure (MAP) 91.1 ± 24.6   
Shock index 1.28 ± .53   
Post-ketamine clinical outcome 
Bradycardia  141 9.3 
Hypotension   548 36.1 
Hypertension  781 51.5 
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2.4 Statistical Analyses 
Data was cleaned and organized to only represent pre-ketamine VS and VS after the first dose of ketamine 
and before the second shot of ketamine was administered (if any second dose was needed). Normality was 
assessed using the Kolmogorov-Smirnov test and Shapiro Wilk test. Where appropriate, the chi-square (χ2) 
or Fisher’s exact test were used to compare categorical data (i.e. patient category versus primary outcome). 
The independent samples t-test or its non-parametric equivalent, the Mann-Whitney U-test, were used to 
compare continuous variables across two groups. Paired data were analyzed using a paired t-test or the non-
parametric Wilcoxon Signed-Rank test when the normality assumption was not met. A hierarchical logistic 
regression model was developed to determine the predictors of bradycardia, hypotension and hypertension 
after ketamine administration. The covariates, age and patient category, were included in the first block, 
followed by the predictors (pre-ketamine vital signs) in the second block. Dose, the moderator, was included 
in the third block. Finally, the interaction terms between dose and the pre-ketamine vital signs were included 
in a fourth block. Results of the logistic regression model were reported as adjusted odds ratio (OR) with 
corresponding 95% CIs. Statistical significance was established at a 5% level (i.e., p-value of < 0.05) for all 
tests. Some limitations of our study are: The inability to control data collection due to the retrospective 
design of our study; Not assessing for tachycardia, gender, body weight, co-morbidities, and adjunctive 
drugs including I.V. fluids and other sedatives; Assessing one point in time without indexing; Not 
considering other complications of intubation that can potentially alter patient’s hemodynamics such as 
intubation difficulties and hypoxia; Lastly, lack of a control group (perhaps “etomidate” the gold standard) 
which reduces it applications. 
An important strength of our study is the big sample size (1,516 patients) that increases the possibility of 
generalized conclusions. Another strength of our study is that we looked at how baseline variations in VS 
may predict post-ketamine clinical outcomes, which most studies have not looked at.  Testing composite 
hemodynamic indices such as MAP and the SI has added value to the applications of our study, for instance 
MAP is a better indicator of cerebral perfusion pressures and therefore including it in the analysis adds 
great value in guiding management in brain injury patients. Also, the SI helps us better stratify at-risk 
patients even when baseline and post-ketamine VS are normal. It is important to remember that the SI can 
be abnormal even when both the BP and HR are normal [22]. Further studies including these indices 
especially the SI would be needed to better determine their usefulness in trauma practice and in guiding 
anesthetic use.  
3 Results 
3.1 Relationship between Pre-Ketamine Vital Signs, Demographic Variables and Post-Ketamine 
Bradycardia 
The development of bradycardia following 
ketamine administration was significantly 
associated with baseline (pre-ketamine) VS 
measures (Figure 1). Patients who 
experienced bradycardia had significantly 
lower pre-ketamine SBP (Mean= 
111.6 mmHg vs. 127.8 mmHg, p < .001), 
DBP (Mean= 66.74 mmHg vs. 77.2 mmHg; 
p < .001), MAP (81.0 mmHg vs. 94.1 
mmHg; p < .001), and HR (82.7 bpm vs. 
102.6 bpm; p < .001) compared to patients 
who did not experience bradycardia. Patients 
who experienced post-ketamine bradycardia 
also had significantly higher pre-ketamine SI 
Figure 1: The Relationship between Pre-Ketamine Vital Signs 
and Post-Ketamine Bradycardia. The asterisk represents 
statistically significant comparisons (p < .001 for all). 
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values compared to those who did not experience 
bradycardia (1.52 mmHg vs. 1.34 mmHg; p= .002).  
On average, patients who experienced bradycardia 
were 13 years older than those who did not (62.2 
years vs. 49. 3 years; p < .001) (Figure 2). A 
significantly higher proportion of medical patients 
developed bradycardia after ketamine when 
compared to trauma patients (12.2 % (n= 89) vs. 
6.6%% (n= 52/786), Chi-square = 13.9, p < .001) 
(Figure 3). P-values obtained from the non-
parametric test (Mann Whitney-U Test for 
continuous data, and Fischer exact test for 
categorical data) were consistent with the results of 
the parametric tests. 
The logistic regression model for the prediction of 
post-ketamine bradycardia showed both MAP and 
SI to be significant predictors for development of 
bradycardia post-ketamine administration (Table 2). 
MAP was a negative predictor of bradycardia as 
indicated by an OR < 1 [OR 0.962, 95% CI (0.947, 
0.976); p < .001]. SI, on the other hand, was a 
positive predictor of bradycardia as indicated by an 
OR > 1. In particular, according to the model, a unit 
increase in the SI increases the odds of experiencing 
bradycardia by more than two-folds [OR 2.61, 95% 
CI (1.35, 5.06); p= .004)]. Age was found to be 
positively associated with bradycardia [OR 1.02, 
95% CI (1.01, 1.04), p < .001)]. Dose (the 
moderator) was also significantly associated with 
bradycardia [OR 1.77, 95% CI (1.08, 2.89), p= .023)]. 
 
 
Table 2: Logistic Regression for pre-Ketamine Vital Signs Predicting Bradycardia,  
controlling for Age and Patient Category. 
 
Variablesab OR 95% CI Wald p-value 
Age 1.02 [1.01, 1.04] 17.4 .000 
Trauma 1.04 [.683, 1.58] .032 .859 
Pre MAP .962 [.947, .976] 25.6 .000 
Pre pulse .987 [.973, 1.00] 3.06 .080 
Pre shock index 2.61 [1.35, 5.06] 8.14 .004 
Dose 1.77 [1.08, 2.89] 5.14 .023 
Pre MAP*dose 1.02 [.987, 1.05] 1.24 .266 
Pre pulse*dose .984 [.956, 1.01] 1.32 .251 
Pre shock*dose .236 [.063, .887] 4.57 .033 
Parameter*dose represents the interaction between the parameters and dose. 
 
Finally, when including the interaction terms for the moderator (dose) in block 4, there was a significant 
gain at a 10% level but not at a 5 % level (Chi-square= 7.35, p= .064). However, the Wald test for the 
interaction terms showed that the interaction between dose and the SI is significant (OR= 0.236, 95% CI 
Figure 2: The Relationship between Age and Post-Ketamine 
Bradycardia. Patients who experienced bradycardia were 
significantly older than patients who did not (p < .001). 
Figure 3: The Relationship between Patient Category and Post-
Ketamine Bradycardia. Medical patients were significantly 
more likely to experience bradycardia after ketamine 
administration than trauma patients (p < .001). 
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(.063, .887); p= .033). The moderation effect 
is represented graphically in Figure 4. In 
particular, the relationship between SI and the 
log of odds of bradycardia is positive and 
stronger for low doses of ketamine 
represented by the solid line. For high doses 
of ketamine, the relationship between SI and 
bradycardia becomes weaker as indicates the 
flatter discontinuous line.  
3.2 Relationship between Pre-Ketamine 
Vital Signs, Demographic Variables, 
and Hypotension 
There were significant differences in all 
baseline VS, except HR, between patients 
who experienced hypotension after ketamine 
administration and those who did not (all p-
values < .001). Patients who experienced 
hypotension had significantly lower baseline 
SBP, DBP, MAP and SI compared (Figure 5). 
Additionally, significant differences in age 
were observed between patients who 
experienced hypotension and those who did 
not (Figure 6). Those who experienced 
hypotension were on average, about 10 years 
older than those who didn’t.  These results 
were consistent with the non-parametric 
tests. Under the Mann-Whitney U, however, 
the differences in HR were also significant 
with the hypotensive group showing slightly 
larger values for baseline HR (p= .029). 
Medical patients were significantly more likely 
to experience hypotension after ketamine 
administration than trauma patients (Chi-
square=36.1, p < .001). In particular, 43.8 % 
(n=320) of medical patients experienced 
hypotension after ketamine administration 
whereas only 29 % (n=228) of trauma patients 
experienced hypotension (Figure 7).  
A logistic regression model for potential 
predictors of post-ketamine hypotension 
showed age [OR 1.03, 95% CI (1.02, 1.03); p 
< .001)] and ketamine dose [OR 1.3, 95% CI 
(1.01, 1.7); p = 0.04] to be positive predictors 
of hypotension and MAP [OR 0.951, 95% CI 
(0.94, 0.96); p < .001)] a negative predictor of 
hypotension. 
Figure 4: Moderation Effect of Dose on Shock Index as a 
Predictor of Bradycardia. 
Figure 5: The Relationship between Pre-Ketamine Vital Signs 
and Post-Ketamine Hypotension. The asterisk represents 
statistically significant comparisons (p < .001 for all). 
Figure 6: The Relationship between Age and Post-Ketamine 
Hypotension. Patients who experienced hypotension were 
significantly older than patients who did not (p < .001). 
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3.3 Relationship between Pre-Ketamine Vital 
Signs, Demographic Variables, and 
Hypertension 
There were significant differences in all baseline 
VS, except HR (pulse), between patients who 
experienced hypertension after ketamine 
administration and those who did not (all p-
values < .001). In particular, patients who 
experienced hypertension after ketamine 
administration had higher values of BP (SBP, 
DBP and MAP) and higher SIs before ketamine 
administration (Figure 8). Those who 
experienced hypertension were also on average 
four years younger (Figure 9). These findings were 
consistent with those obtained from the non-
parametric tests. 
Trauma patients were significantly more likely to 
experience hypertension after ketamine administration 
than medical patients (Chi-square = 46.18, p < .001). 
In particular, 59.9 % (n= 471) of trauma patients 
experienced hypertension after ketamine 
administration whereas only 42.5 % (n= 310) of 
medical patients did (Figure 10). 
A logistic regression model for potential predictors of 
post-ketamine hypertension showed trauma patients to 
be 1.67 times more likely to develop hypertension than 
medical patients [OR 1.67, 95% CI (1.31, 2.13); p < 
.001)]. It also showed pre-ketamine MAP to be a slight 
positive predictor of hypertension after ketamine 
administration [OR 1.03, 95% CI (1.02, 1.04): p < .001)]. 
Higher ketamine dose (>150 mg) was also a positive 
predictor of hypertension [OR 1.3, 95% CI (1.04, 1.62); 
p = .02)].   
Figure 7: The Relationship between Patient Category and Post-
Ketamine Hypotension. Medical patients were significantly 
more likely to experience hypotension after ketamine 
administration than trauma patients (p < .001). 
Figure 8: The Relationship between Pre-Ketamine Vital Signs 
and Post-Ketamine Hypertension. The asterisk represents 
statistically significant comparisons (p < .001 for all). 
Figure 10: The Relationship between Patient Category and 
Post-Ketamine Hypertension. Trauma patients were 
significantly more likely to experience hypertension after 
ketamine administration than medical patients (p < .001). 
Figure 9: The Relationship between Age and Post-Ketamine 
Hypertension. Patients who experienced hypertension were 
significantly younger than patients who did not (p < .001). 
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3.4 Comparing Vital Signs Before and After Ketamine 
There was a significant difference between pre-ketamine and post-ketamine SBP, MAP, and SI when paired 
hemodynamic measures of the same individual were compared. Following ketamine administration, on 
average, the SBP decreased by 4 units (p < .001, paired-t-test), the MAP decreased by 1.75 units (p < .001, 
paired-t-test) and the SI decreased by 0.07 units (p < .001, paired-t-test). These findings were consistent 
with those obtained from the equivalent non-parametric test, the Wilcoxon signed ranks test (Table 3). 
Table 3: Paired T-test Comparing Vital Signs Before and After Ketamine 
3.5 Relationship between Ketamine Dose and Post-Ketamine Clinical Outcomes 
Table 4 shows the relationship between 
ketamine dose and post-ketamine clinical 
outcomes. There was a significant association 
between ketamine dose and the development 
of post-ketamine bradycardia (Chi-
square=19.3, p < .001) and hypertension 
(Chi-square=19.3, p = .001). Patients who 
received higher doses of ketamine were more 
likely to experience bradycardia and 
hypertension. It was found that only 8% of 
patients who did not experience bradycardia 
received a ketamine dose  200 mg while 16% 
of those who experienced bradycardia 
received a dose of ketamine  200 mg (Figure 
11). Patients who developed hypertension 
received moderately higher ketamine doses 
than patients who did not develop 
hypertension, with most doses being between 
151-200 mg (Figure 11). The development of 
post-ketamine hypotension was not affected 
by differences in the ketamine dose (Chi-
square=19.3, p = .116).  
Figure 1: Differences in Ketamine Doses across Different Clinical Outcomes 
Table 4: Relationship between Ketamine Dose and Study Outcomes 
  Clinical Outcome 
Ketamine dose Total Number 
of Patients (n) 
Bradycardia  
n (row %) 
Hypotension  
n (row%) 
Hypertension  
n (row%) 
  Yes No Yes No Yes No 
 100 mg 266 32 (12) 234 (88) 112 (42.1)  154 (57.9) 121 (45.5) 145 (54.5) 
101-150 mg 489 29 (5.9) 460 (94.1) 164 (33.5) 325 (66.5) 230 (47) 259 (53) 
151-200mg 629 57 (9) 572 (91) 222 (35.3) 407 (64.7) 358 (57) 271 (43) 
>200 mg 132 23 (17.4) 109 (82.6) 50 (37.9) 82 (62.1) 72 (54.5) 60 (45.5) 
Vital signs Pre-Ketamine  
mean ± SD 
Post-Ketamine,  
mean ± SD 
p-value1 p-value2 
     Systolic BP 126.3 ± 33.6  122.2 ± 33.5 .000 .000 
Diastolic BP  76.2 ± 20.4  75.6 ± 21.2 .252 .502 
Pulse (HR) 100.1 ± 25.7  101.6 ± 24.6 .131 .127 
Mean arterial pressure (MAP) 92.9 ± 23.9  91.1 ± 24.6 .001 .009 
Shock index 1.35 ± .55 1.28 ± .53 .000 .000 
1 p-value corresponds to the paired Student’s t-test 
2 p-value corresponds to the non-parametric Wilcoxon signed ranks test 
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4 Discussion 
Out of a total of 1,516 patients, 141 (9.3%) experienced bradycardia, 548 (36.1%) experienced hypotension 
and 781 (51.5%) experienced hypertension following ketamine administration (Table 1). On bivariate 
analysis, lower baseline (pre-ketamine) HR was associated with post-ketamine bradycardia but not with 
changes in BP. Baseline BP measurements were better determinants of post-ketamine changes in BP. 
Patients with lower baseline SBP, DBP, and MAP were significantly more likely to experience bradycardia 
(Figure 1) and hypotension (Figure 5) after ketamine administration. In contrast, patients with higher 
baseline SBP, DBP, and MAP were significantly more likely to develop hypertension after ketamine 
administration (Figure 8). Lower baseline SI was associated with post-ketamine hypotension (Figure 5), 
while higher baseline SI was associated with bradycardia (Figure 1) and hypertension (Figure 8). Age was 
an important determinant of post-ketamine response. Patients who experienced bradycardia (Figure 2) and 
hypotension (Figure 6) were on average 10-13 years older and those who experienced hypertension were 
on average 4 years younger (Figure 9) than those who did not experience either. Medical patients were more 
likely to experience bradycardia (Figure 3) and hypotension (Figure 7) after ketamine administration, while 
trauma patients were more likely to experience hypertension (Figure 10).  Higher doses of ketamine caused 
more bradycardia and hypertension than lower doses (Table 4). Particularly, extremely high doses (> 200 
mg) were associated with bradycardia and moderately high doses (151-200 mg) were associated with 
hypertension. Post-ketamine hypotension did not seem to be related to ketamine dose on the bivariate 
analysis.  
On multivariate regression analysis, older patients were slightly more likely to experience bradycardia and 
hypotension after ketamine administration than younger patients. Also, trauma patients were 1.67 times 
more likely to develop hypertension than medical patients. Interestingly, the multivariate logistic regression 
showed baseline composite hemodynamic measures such as MAP and SI to be significant predictors of the 
ketamine response but not the non-composite measures such as HR, SBP, and DBP. Higher baseline MAP 
was found to slightly increase the risk of hypertension, but it was somewhat protective against bradycardia 
and hypotension. Baseline SI was found to be a positive predictor of post-ketamine bradycardia with the 
odds of experiencing bradycardia after ketamine administration increasing by over two-folds for every unit 
increase in baseline SI.   Also, patients who received ketamine doses > 150 mg were 1.3 times more likely 
to develop hypotension or hypertension and 1.77 times more likely to experience bradycardia after ketamine 
administration when compared to patients who received doses <150 mg. Lastly, we tested the ketamine 
dose as a moderator of potential predictors of ketamine outcomes and found that ketamine dose only 
affects the relationship between pre-ketamine SI and post-ketamine bradycardia. The increase in the - odds 
of bradycardia for changes in SI was greater at lower doses of ketamine and less dependent on baseline SI 
values at higher doses (Figure 4). This may partially be explained by the increased occurrence of 
hypertension at high ketamine doses, which may have caused a reflex bradycardia that may not otherwise 
have happened in apparently lower risk patients (i.e. those with lower SI). Nonetheless, it is also possible 
that at higher doses (>200 mg) ketamine may directly affect the heart in both low and high SI patients.  It 
seems that ketamine dose is an important determinant of hemodynamic changes that follow its 
administration. The concept of a continuum of sedation and dose-dependent adverse events as a 
characteristic of non-dissociative sedatives is familiar to physicians [23]. Evidence suggests that ketamine 
does not exhibit any such dose-related adverse events within the range of clinically administered doses using 
standard administration techniques [24], [25]. However, most of the evidence comes from published studies 
that looked at side effects other than cardiovascular changes. We believe that ours was the first study to 
document dose as a moderator of the hemodynamic response to ketamine. In particular, ketamine appears 
to affect bradycardia and hypertension, in a dose-dependent fashion, and the dose of ketamine can 
moderate how other factors affect the post-ketamine outcome.  
When comparing our study to previous studies that looked at similar cardiovascular parameters in the 
context of ketamine use in either a pre-hospital or emergency setting, we found similar results with some 
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differences that may be explained by various factors such as sample size, and differing definitions of 
endpoints. Price et al. [26] conducted a retrospective study that compared the hemodynamic effects of 
etomidate with that of ketamine in 100 patients undergoing ETI in a pre-hospital setting. The researchers 
assessed up to two sets of VS before ETI and up to five sets of VS after ETI. The median pre-ketamine 
HR was 99-100 bpm and the median post-ketamine HR was 92-101 bpm. The median pre-drug SBP was 
128-140 mmHg and the median post-drug SBP was 123-137 mmHg.  Similar to their study, in our study, 
the mean pre-ketamine was HR 100.8 and SBP was 126.3 mmHg while the mean post-ketamine HR was 
101.6 and SBP was 122 mmHg (Table 1). The rates of occurrence of bradycardia (12% vs. 9.3%), 
hypotension (24% vs. 36,1%), and hypertension (30% vs. 51%) in their study and our study respectively 
were also comparable.  We observed slightly greater percentages of hemodynamic events than Price et al. 
[26] and this may be due to differences in the way the events were defined and the fact that we did not 
specifically count those who developed new cardiovascular abnormalities but rather counted the total 
number of post-ketamine endpoints. Sibley et al. [27] prospectively reviewed the use of ketamine to facilitate 
ETI in 71 patients in an HEMS setting and found ketamine to be an effective agent with similar 
complication rates to the control agent. In their study, they reported bradycardia in one (1%), hypotension 
in five (7%), and hypertension in four (6%) patients [27]. The rates of hemodynamic events in their study 
were significantly lower than in our study. Also, the changes in MAP (2.3 mmHg) and HR (0.45 bpm) after 
ketamine administration did not reach statistical significance in their study [27]. Their inability to detect any 
difference between pre- and post-ketamine MAP could be due to reduced power. Our study detected 
significant differences between pre- and post- ketamine MAP (Table 3) but not HR. Ballow et al. [28] 
compared the outcomes in 177 patients who received a ketamine protocol for RSI to 266 patients who 
received pre-protocol regimens that included midazolam, fentanyl, and etomidate with a muscle relaxant 
and reported hypotension in only 3.6% of patients in the ketamine group compared to 6 % in the non-
ketamine group.  Their study, despite the reasonable sample size, reported significantly lower hypotensive 
events than our study. It appears that the development of hemodynamic complications after ketamine 
administration probably depends on many factors that include, but are not limited to patient factors, and 
perhaps ketamine doses. 
Studies that have looked at the role of baseline SI in predicting the development of hemodynamic events 
following ketamine for RSI in trauma and emergency patients are very scarce. Among the published 
literature, only one study described how baseline SI relates to hemodynamic changes after ketamine 
induction in the out-hospital setting [29] .  In this study, researchers found that patients with a high SI 
exhibited blunted hypertensive responses and more frequent hypotension following ketamine induction, 
whereas patients with a low SI had sustained increases in HR and SBP [29]. These results agree with our 
findings. Patients who were likely to develop shock were more likely to develop hypotension after ketamine. 
On the other hand, patients with lower SI scores were less likely to develop hypotension but were more 
likely to develop hypertension and bradycardia. It is well known that a high SI predicts mortality in acute 
polytrauma patients [30], [31]. A more recent study showed that elevated SI predicts death in all trauma 
patients, but low SI values predicted death in head injured patients. Unfortunately, we did not test SI as an 
outcome to determine which factors determined higher or lower SI, but we did find a significant drop in 
the SI from 1.35 ± .55 at baseline to 1.28 ± .53 after ketamine on pre-post ketamine vs. testing. 
In summary, we can clearly state that despite ketamine’s cardiovascular “boosting “effect that renders it 
highly desirable in trauma patients who are frequently hypotensive or in shock, it may cause hemodynamic 
instability in select patients. Ketamine increases the central nervous system sympathetic outflow and 
decreases the reuptake of catecholamines producing an increase in BP, HR and stroke volume while 
maintaining systemic vascular resistance. On the other hand, it can also cause cardiac depression after 
induction. Ketamine’s cardiac depressant effects are commonly overlooked because these effects are 
masked by its ability to increase sympathetic outflow. Therefore, in patients who are not catecholamine 
depleted, ketamine will produce a dose-related rise in the heart rate–systolic blood pressure product, leading 
to a transient rise in the cardiac index [32], [33] while in patients who are apparently catecholamine depleted 
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and lack autonomic control will experience direct myocardial depressant effects, leading to dose-dependent 
negative inotropic and chronotropic effects [34], [35]. This may explain why we observed hypotension and 
bradycardia more frequently in medical patients who probably are severely ill and catecholamine depleted 
given their need for intubation. It may also indirectly explain why hypotension was less associated with 
ketamine dose, as physicians are more likely to give lower doses of ketamine to the more severely ill patients 
with multiple comorbidities, who are the same patients that are more likely to develop hypotension with 
ketamine. Nonetheless, ketamine remains a useful anesthetic for RSI and in many studies has proven to be 
as effective as the gold standard “etomidate” with some favoring ketamine in some circumstances [19] .  
5 Conclusion 
In conclusion, baseline vital signs (HR, SBP, DBP, MAP, and SI) may help predict the hemodynamic 
response to ketamine during RSI. The results of this study indicate that older age, lower baseline vitals, and 
being a medical patient versus a trauma patient is more likely to predict the development of bradycardia 
and/or hypotension following the administration of ketamine during RSI. On the other hand, younger 
subjects, higher baseline vitals and trauma patients were more likely to develop hypertension following 
ketamine administration.  Furthermore, the results suggest that higher doses of ketamine were associated 
with developing bradycardia and hypotension or hypertension. Understanding how baseline vital signs 
effect the response to ketamine administration will help first responders and trauma/emergency personnel 
better identify who may benefit from ketamine versus those who may potentially develop adverse events 
such as hypotension and bradycardia. This will enable healthcare professionals to improve upon current 
mortality and morbidity rates associated with RSI.  Our study also provides key information to help 
researchers better design future studies to develop succinct guidelines for the use of ketamine in RSI. 
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